These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 16334202

  • 1. [Polycythemia vera].
    Rain JD.
    Rev Prat; 2005 Oct 15; 55(15):1659-68. PubMed ID: 16334202
    [Abstract] [Full Text] [Related]

  • 2. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Haematologica; 2001 Apr 15; 86(4):368-74. PubMed ID: 11325641
    [Abstract] [Full Text] [Related]

  • 3. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
    Bai J, Shao ZH, Liu H, Shi J, He GS, Cao YR, Cui ZZ, Wu YH, Sun J, Tian Z, Jia HR, Qian LS, Yang TY, Yang CL.
    Chin Med J (Engl); 2004 May 15; 117(5):668-72. PubMed ID: 15161531
    [Abstract] [Full Text] [Related]

  • 4. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2013 Jun 15; 88(6):507-16. PubMed ID: 23695894
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and therapy of polycythemia vera.
    Lengfelder E, Merx K, Hehlmann R.
    Semin Thromb Hemost; 2006 Apr 15; 32(3):267-75. PubMed ID: 16673281
    [Abstract] [Full Text] [Related]

  • 6. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2011 Mar 15; 86(3):292-301. PubMed ID: 21351120
    [Abstract] [Full Text] [Related]

  • 7. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr 15; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR.
    Semin Hematol; 1986 Apr 15; 23(2):132-43. PubMed ID: 3704665
    [Abstract] [Full Text] [Related]

  • 9. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.
    Orv Hetil; 2006 Nov 12; 147(45):2175-9. PubMed ID: 17402211
    [Abstract] [Full Text] [Related]

  • 10. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC.
    Hum Pathol; 2008 Oct 12; 39(10):1454-8. PubMed ID: 18619646
    [Abstract] [Full Text] [Related]

  • 11. [Polycythaemia vera--diagnosis and therapy].
    Lechner K, Geissler K, Gisslinger H.
    Wien Klin Wochenschr; 1999 Aug 20; 111(15):582-9. PubMed ID: 10483672
    [Abstract] [Full Text] [Related]

  • 12. A contemporary approach to the diagnosis and management of polycythemia vera.
    Tefferi A.
    Curr Hematol Rep; 2003 May 20; 2(3):237-41. PubMed ID: 12901345
    [Abstract] [Full Text] [Related]

  • 13. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J, Kvasnicka HM.
    Pathobiology; 2007 May 20; 74(2):89-96. PubMed ID: 17587880
    [Abstract] [Full Text] [Related]

  • 14. The diagnosis of polycythemia vera: new tests and old dictums.
    Tefferi A.
    Best Pract Res Clin Haematol; 2006 May 20; 19(3):455-69. PubMed ID: 16781483
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
    Mossuz P, Girodon F, Donnard M, Latger-Cannard V, Dobo I, Boiret N, Lecron JC, Binquet C, Barro C, Hermouet S, Praloran V.
    Haematologica; 2004 Oct 20; 89(10):1194-8. PubMed ID: 15477203
    [Abstract] [Full Text] [Related]

  • 16. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
    Michiels JJ, De Raeve H, Hebeda K, Lam KH, Berneman Z, Schroyens W, Schwarz J.
    Leuk Res; 2007 Aug 20; 31(8):1031-8. PubMed ID: 17367853
    [Abstract] [Full Text] [Related]

  • 17. [Polycythemia vera and pregnancy: difficulties for diagnosis and treatment].
    Deruelle P, Bouhassoun J, Trillot N, Jude B, Ducloy AS, Subtil D.
    Gynecol Obstet Fertil; 2005 May 20; 33(5):331-7. PubMed ID: 15878688
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera.
    Le Gall C, Ianotto JC, Hardy E, Ugo V, Eveillard JR, Ngo-Sack F, Bourquard P, Morice P, Berthou C.
    Leuk Res; 2008 May 20; 32(5):743-54. PubMed ID: 17980427
    [Abstract] [Full Text] [Related]

  • 19. How to manage polycythemia vera.
    Passamonti F.
    Leukemia; 2012 May 20; 26(5):870-4. PubMed ID: 22157736
    [Abstract] [Full Text] [Related]

  • 20. Contribution of bone marrow biopsy in the diagnosis and prognosis of polycythemia vera.
    de Mascarel A.
    Nouv Rev Fr Hematol (1978); 1994 Apr 20; 36(2):165-6. PubMed ID: 8036134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.